mynth
← DATABASE
08/2025

Innovad Group acquired by PAI PARTNERS

BELGIUM Life Sciences / Animal Health REV €100–200M

Context

A control buyout transaction has been agreed by private equity firm PAI Partners to acquire Innovad Group from IK Partners, initiating the next strategic expansion cycle for the specialty animal feed additives business. The transaction provides a full monetization event for the seller's IK IX Fund, which held its equity position since 2021. In conjunction with the buyout, the incumbent leadership team headed by Chief Executive Officer Ben Letor is reinvesting alongside the incoming financial sponsor to ensure management continuity and execute the long-term roadmap. Under the prior holding period, the platform delivered consistent double-digit revenue growth, commercialized the proprietary Myco-Marker biomonitoring diagnostic tool, and successfully integrated three strategic add-on acquisitions that broadened its phytogenic capabilities. At the time of the deal, the Belgium-headquartered company operates six production facilities, combining three proprietary manufacturing sites in Belgium, Brazil, and Italy with specialized tolling partners in Switzerland and Italy, serving 900 customers across 75 countries. The value creation plan established by PAI Partners leverages its domain expertise in food, ingredients, and animal nutrition to accelerate organic commercial momentum, increase scientific development capabilities, and execute selective cross-border add-ons. Closing of the deal is targeted for the first quarter of 2026, subject to customary closing conditions.

In the past, the company underwent an LBO led by Ik Partners in 2021, and continued an active consolidation strategy by notably acquiring Herbonis (2023).

Innovad Group, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Innovad Group is a globally operating supplier of specialty additives for animal feed, concentrating on poultry, ruminant and swine species. Its portfolio comprises high‑value solutions that support gut health, mycotoxin mitigation and immune function, with a pronounced emphasis on phytogenic and biomonitoring technologies. Headquartered in Antwerp, Belgium, the company serves roughly 900 customers across 75 markets. Production capacity is vertically integrated through three owned facilities in Belgium, Brazil and Italy, complemented by toll‑manufacturing partnerships in Switzerland and Italy. Innovad’s R&D platform drives the development of novel nutraceutical ingredients and a proprietary mycotoxin biomonitoring tool. The firm pursues organic expansion, strategic acquisitions and continuous enhancement of its development platform to reinforce its position as a leading specialist in animal nutrition additives.

Ent. Value

€100–200M

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2023
€100–200M
€25–50M
€10–30M
2022
€100–200M
€25–50M
€10–30M

Other operations with Innovad Group

Other operations with Innovad Group

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
04/2023Innovad GroupHerbonisSWITZERLANDAnimal Health
02/2021IK PARTNERSInnovad GroupBELGIUMAnimal Health

REFERENCES

Revenue range: €100–200M

EBITDA range: €25–50M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Innovad Group by PAI PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: innovad group

Acquirer: pai partners